 Chemokine CXCL1
"Chemokine CXCL1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine with specificity for CXCR2 RECEPTORS. It has growth factor activities and is implicated as a oncogenic factor in several tumor types.
| Descriptor ID |
D054360
|
| MeSH Number(s) |
D12.644.276.374.200.120.050 D12.776.467.374.200.120.050 D12.776.624.664.700.049 D23.125.300.120.050 D23.469.200.120.050 D23.529.374.200.120.050
|
| Concept/Terms |
Chemokine CXCL1- Chemokine CXCL1
- CXCL1, Chemokine
- CXCL1 Chemokine
- Chemokine, CXCL1
- Gro-alpha Protein
- Gro alpha Protein
- GROalpha Protein
- Melanoma Growth Stimulatory Activity, alpha Protein
- MGSA-alpha Chemokine
- Chemokine, MGSA-alpha
- MGSA alpha Chemokine
- Neutrophil-Activating Protein 3
- Neutrophil Activating Protein 3
- Chemokine (C-X-C Motif) Ligand 1
- Growth-Related Oncogene alpha Protein
- Growth Related Oncogene alpha Protein
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL1".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL1".
This graph shows the total number of publications written about "Chemokine CXCL1" by people in this website by year, and whether "Chemokine CXCL1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1997 | 0 | 2 | 2 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 2 | 2 | | 2004 | 0 | 2 | 2 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2007 | 0 | 2 | 2 | | 2008 | 0 | 2 | 2 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2011 | 0 | 5 | 5 | | 2012 | 1 | 2 | 3 | | 2013 | 0 | 1 | 1 | | 2014 | 0 | 2 | 2 | | 2015 | 0 | 2 | 2 | | 2018 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 | | 2020 | 0 | 2 | 2 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chemokine CXCL1" by people in Profiles.
-
Kouwenberg M, Pulskens WPC, Diepeveen L, Bakker-van Bebber M, Dinarello CA, Netea MG, Hilbrands LB, van der Vlag J. Reduced CXCL1 production by endogenous IL-37 expressing dendritic cells does not affect T cell activation. PLoS One. 2021; 16(5):e0251809.
-
Idrovo JP, Boe DM, Kaahui S, Yang WL, Kovacs EJ. Hepatic inflammation after burn injury is associated with necroptotic cell death signaling. J Trauma Acute Care Surg. 2020 10; 89(4):768-774.
-
Graham ZA, Goldberger A, Azulai D, Conover CF, Ye F, Bauman WA, Cardozo CP, Yarrow JF. Contusion spinal cord injury upregulates p53 protein expression in rat soleus muscle at multiple timepoints but not key senescence cytokines. Physiol Rep. 2020 02; 8(3):e14357.
-
Nguyen L, Sandoval J, De Dios R, Yihdego E, Zarate M, Castro O, McKenna S, Wright CJ. The hepatic innate immune response is lobe-specific in a murine model endotoxemia. Innate Immun. 2019 02; 25(2):144-154.
-
Karim H, Kim SH, Lapato AS, Yasui N, Katzenellenbogen JA, Tiwari-Woodruff SK. Increase in chemokine CXCL1 by ER? ligand treatment is a key mediator in promoting axon myelination. Proc Natl Acad Sci U S A. 2018 06 12; 115(24):6291-6296.
-
Zhao W, Siegel D, Biton A, Tonqueze OL, Zaitlen N, Ahituv N, Erle DJ. CRISPR-Cas9-mediated functional dissection of 3'-UTRs. Nucleic Acids Res. 2017 Oct 13; 45(18):10800-10810.
-
Ozkok A, Ravichandran K, Wang Q, Ljubanovic D, Edelstein CL. NF-?B transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI). Toxicol Lett. 2016 Jan 05; 240(1):105-13.
-
Stolberg VR, McCubbrey AL, Freeman CM, Brown JP, Crudgington SW, Taitano SH, Saxton BL, Mancuso P, Curtis JL. Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function. J Immunol. 2015 Jul 01; 195(1):174-84.
-
Ravichandran K, Ozkok A, Wang Q, Mullick AE, Edelstein CL. Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2. Am J Physiol Renal Physiol. 2015 Feb 15; 308(4):F349-57.
-
Chen MM, Palmer JL, Plackett TP, Deburghgraeve CR, Kovacs EJ. Age-related differences in the neutrophil response to pulmonary pseudomonas infection. Exp Gerontol. 2014 Jun; 54:42-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|